Templeton v. Emcare, Inc.

868 F. Supp. 2d 333, 2012 WL 2196138, 2012 U.S. Dist. LEXIS 83362
CourtDistrict Court, D. Delaware
DecidedJune 15, 2012
DocketCiv. No. 11-808-SLR
StatusPublished
Cited by9 cases

This text of 868 F. Supp. 2d 333 (Templeton v. Emcare, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Templeton v. Emcare, Inc., 868 F. Supp. 2d 333, 2012 WL 2196138, 2012 U.S. Dist. LEXIS 83362 (D. Del. 2012).

Opinion

MEMORANDUM OPINION

SUE L. ROBINSON, District Judge.

I. INTRODUCTION

On September 13, 2011, plaintiff Philip A. Templeton, M.D., P.A. (“plaintiff’) filed a complaint seeking judgment on an alleged payment due under a Membership Interest Purchase Agreement (“Purchase Agreement”) entered into by plaintiff and EmCare, Inc. (“defendant”) on October 17, 2008. (D.I. 1 at ¶ 8) The Purchase Agreement set forth the terms of defendant’s acquisition of plaintiffs issued and outstanding membership interests. (Id. at ¶ 10) Plaintiffs complaint seeks declaratory judgment pursuant to 28 U.S.C. §§ 2201-02 and, in the alternative, pleads both breach of contract and breach of the implied covenant of good faith and fan-dealing. (Id. at ¶¶ 37-63)

On November 18, 2011, defendant answered the complaint, asserting several affirmative defenses and a counterclaim adding Dr. Philip A. Templeton (“Templeton”) as a second counterclaim defendant. The counterclaim asserts five counts: (1) breach of § 2.3 of the Purchase Agreement; (2) breach of § 8.3 of the Purchase Agreement; (3) breach of the implied covenant of good faith and fair dealing; (4) fraudulent misrepresentation; and (5) fraudulent inducement to contract. (D.I. 9 at ¶¶ 48-84)1 Defendant seeks damages of no less than $10 million. (Id. at 30-31) Presently before the court is a partial motion to dismiss defendant’s counterclaims, filed by plaintiff on January 6, 2012. (D.I. 18) Plaintiff moves to dismiss counts one, three, four and five of the counterclaim. (Id.)

II. BACKGROUND

A. The Parties

Plaintiff is a professional association that exists under the laws of the State of Mary[337]*337land and has its principal place of business in the State of Maryland. Plaintiff provides retail teleradiology services, whereby a physician reviews and interprets radiological patient images such as x-rays and CT scans that are transmitted electronically, thus allowing the physician to provide patient services remotely. (D.I. 9 at ¶ 10)

Templeton, a resident and citizen of the State of Maryland, is the sole shareholder of plaintiff.2 (Id. at ¶ 3)

Defendant is a Delaware corporation with its principal place of business in Dallas, Texas. Defendant is a provider of various physician, anesthesiology and radiology services. (Id. at ¶ 8)

All three entities are parties to the October 17, 2008 Purchase Agreement.

B. The Purchase Agreement

In 2008, defendant entered into discussions with plaintiff to negotiate the acquisition of Templeton’s teleradiology practice. (Id. at ¶¶ 9, 12) During negotiations, plaintiff allegedly claimed expertise in retail teleradiology in addition to a large customer base, including several new customers who were ready to close contracts once the acquisition finalized. (Id. at ¶ 12) Negotiations culminated in the drafting of the Purchase Agreement and the sale of the membership interests of the teleradiology practice to defendant for $27.5 million. (Id. at ¶ 14) As a condition of closing, defendant insisted that Templeton remain as the president of the practice. (Id. at ¶ 15) In his capacity as president, Temple-ton would “reasonably cooperate with [defendant] ... in their efforts to continue and maintain business relationships of [plaintiff]” as they existed prior to closing. (Id. at ¶ 16)

To encourage compliance with this clause, the parties agreed to incorporate an “Earn-Out Consideration” into the Purchase Agreement. Section 2.3 states that plaintiff “shall be entitled to receive from [defendant] an Earn-Out Payment or [defendant] shall be entitled to receive payment of the Deficiency Amount from [plaintiff]” depending on plaintiffs earning before interest, taxes, depreciation, and amortization (“EBITDA”) for 2009. (Id. at ¶ 17) If plaintiff reached a certain minimum EBITDA (the “Earn-Out Threshold”) during 2009 (the “Earn-Out Period”), defendant would pay seven times the EBITDA in excess of the Earn-Out Threshold up to $10 million. (Id. at ¶ 19) Likewise, if plaintiff failed to reach a certain EBITDA (the “Earn-Out Floor”) during the Earn-Out Period, it would pay seven times the difference between the Earn-Out Floor and the EBITDA up to $10 million (the “Deficiency Amount”). (Id.) The Purchase Agreement required defendant to provide plaintiff with a written calculation of the Deficiency Amount no later than March 1, 2010. (Id. at ¶ 39)

Neither party disputes that § 11.12 of the Purchase Agreement states that “[t]ime is of the essence of this Agreement.” (D.I. 1, ex. A at 43) However, defendant asserts this clause is merely a “boilerplate, general, free-floating provision” due to its location in the “Miscellaneous” section. (D.I. 9 at ¶ 13) Defendant further claims that this provision was neither discussed nor negotiated at the time of contract formation. (Id.)

C. Disagreement on Purchase Agreement Obligations

During 2009, plaintiff allegedly failed to close deals with new customers and lost [338]*338existing customers. (Id. at ¶ 25) Defendant claims it was plaintiffs responsibility to prepare monthly financial reports and that plaintiff was in possession of all the necessary financial information that would have allowed it to predict a year-end EBITDA shortfall. (Id. at ¶ 23) Consistent with this assertion, plaintiff supposedly expressed concern over the prospect of an EBITDA deficit. (Id. at ¶ 28) The practice floundered despite defendant’s allegations that it channeled business to plaintiff from its own physician services throughout 2009 to help plaintiff achieve the minimum EBITDA and that it held regular operating reviews with plaintiff. (Id. at ¶ 22)

As the deadline for the year-end EBITDA calculations drew near, defendant contends that it orally extended the Earn-Out calculation date to allow plaintiff more time to reach the Earn-Out Threshold, and that these extensions continued throughout 2010. (Id. at ¶¶ 30, 34) Defendant provided plaintiff with an income statement in early 2010 that confirmed a large EBITDA shortfall which would result in the maximum payment of $10 million. (Id. at ¶ 32) Eventually, defendant sent a formal letter to plaintiff demanding the $10 million payment along with a calculation of the Deficiency Amount. (Id. at ¶ 36)

Plaintiff responded through counsel that, because defendant provided the letter more than 60 days after the December 31, 2009 deadline mandated by the Purchase Agreement, payment was no longer due. (Id. at ¶ 39) Defendant contends that plaintiff waived the “time is of the essence” clause by agreeing to extensions to pay the Deficiency Amount and that accepting the extensions was a scheme to avoid payment. (Id. at ¶¶ 41, 44)

III. STANDARD OF REVIEW

In reviewing a motion to dismiss filed under Fed.R.Civ.P. 12(b)(6), the court must accept the factual allegations of the non-moving party as true and draw all reasonable inferences in its favor. See Erickson v. Pardus,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
868 F. Supp. 2d 333, 2012 WL 2196138, 2012 U.S. Dist. LEXIS 83362, Counsel Stack Legal Research, https://law.counselstack.com/opinion/templeton-v-emcare-inc-ded-2012.